One large IPO is currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week.
Medtronic diabetes business carve-out MiniMed (MMED) plans to raise $742 million at a $7.4 billion market cap. MiniMed focuses on integrated diabetes management, including insulin delivery devices, continuous glucose monitors (CGMs), infusion sets, reservoirs, pen systems, and related software and services. The company’s user base exceeds 640,000 individuals on insulin pumps as of October 2025 and its CGM attachment rate reached 65% in the six months ended October 24, 2025.
Clinical-stage "live biopharmaceuticals" biotech Salspera (TKVA), which filed IPO terms this past week, may price an $85 million offering in the week ahead, though timing is not confirmed. The company has filed to offer 5.7 million shares at a range of $14 to $16, for an implied market cap of more than $900 million. The lead manager is Kingswood Capital Partners.
While not included below, Robinhood Ventures Fund I (RVI), a closed-end fund formed by Robinhood, is also set to list in the week ahead. The fund holds investments in a portfolio of private growth companies, including several notable IPO candidates.
| U.S. IPO Calendar | |||
|---|---|---|---|
| Issuer Business | Deal Size Market Cap | Price Range Shares Filed | Top Bookrunners |
| MiniMed (MMED) Northridge, CA | $742M $7,442M | $25 - $28 28,000,000 | Goldman BofA |
| Carve-out of Medtronic's diabetes management devices and technology business. | |||
Sign up for a free trial of our premium platform, IPO Pro. To get our IPO calendar in your inbox, register here.
Street research is expected for seven companies in the week ahead, and one lock-up period will be expiring. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 2/26/2026, the Renaissance IPO Index was down 0.6% year-to-date, while the S&P 500 is up 1.1%. Renaissance Capital’s IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include CoreWeave (CRWV) and Kenvue (KVUE). The Renaissance International IPO Index was up 16.4% year-to-date, while the ACWX was up 11.2%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Kioxia and JX Advanced Metals.
